Publication:
Neuroblastoma Occurring in Nijmegen Breakage Syndrome

dc.contributor.authorDjurisic, Marina (12769932200)
dc.contributor.authorSarajlija, Adrijan (26027638400)
dc.contributor.authorRadivojevic, Danijela (12769357500)
dc.contributor.authorCirkovic, Sanja (56627166200)
dc.contributor.authorDjokic, Dragoljub (36619461900)
dc.contributor.authorDjuricic, Slavisa (6603108728)
dc.contributor.authorSamardzija, Gordana (56177152500)
dc.contributor.authorPasic, Srdjan (55904557400)
dc.date.accessioned2025-06-12T11:38:02Z
dc.date.available2025-06-12T11:38:02Z
dc.date.issued2025
dc.description.abstractNijmegen breakage syndrome (NBS) is a rare primary immunodeficiency disease due to a pathogenic variant in the NBN gene causing impaired DNA repair and increased predisposition for lymphoid malignancy. By contrast, solid tumors have been rarely reported. Neuroblastoma (NB) is a rare childhood solid tumor, associated with the worse outcome if MYCN oncogene is amplified. We describe 2 young pediatric patients with NBS who developed high-risk NB. The first patient died shortly after chemotherapy was introduced. The second patient successfully received modified chemotherapy resulting in clinical remission lasting 2 years after an initial diagnosis of NB. © 2024 Wolters Kluwer Health, Inc. All rights reserved.
dc.identifier.urihttps://doi.org/10.1097/MPH.0000000000002965
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85210306734&doi=10.1097%2fMPH.0000000000002965&partnerID=40&md5=9473206e1d8acd2f249bd40850c29216
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/658
dc.subjectDNA damage response
dc.subjectMYCN amplification
dc.subjectNBN gene
dc.subjectneuroblastoma
dc.subjectNijmegen breakage syndrome
dc.titleNeuroblastoma Occurring in Nijmegen Breakage Syndrome
dspace.entity.typePublication

Files